General Information of This Metabolic Reaction (MR) (ID: MR000402)
Formula
SVG example
Hydrolysis
Reactant Bortezomib metabolite M2 Product Bortezomib metabolite M3
Reactant Info Product Info
Metabolic Type Hydrolysis - Hydrolysis
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000409 Bortezomib Bortezomib metabolite M2 Oxidation - Oxidation; Deboronation Bortezomib [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000405 Bortezomib metabolite M2 Bortezomib metabolite M27 Oxidation - Hydoxylation Bortezomib [1]
MR000404 Bortezomib metabolite M2 Bortezomib metabolite M28 Oxidation - Hydoxylation Bortezomib [1]
MR000406 Bortezomib metabolite M2 Bortezomib metabolite M6 Oxidation - Hydoxylation Bortezomib [1]
MR000403 Bortezomib metabolite M2 Bortezomib metabolite M8 Oxidation - Hydoxylation Bortezomib [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000397 Bortezomib metabolite M1 Bortezomib metabolite M3 Hydrolysis - Hydrolysis Bortezomib [1]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000401 Bortezomib metabolite M3 Bortezomib metabolite M4 Unclear Bortezomib [1]
References
1 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.